Cidara Therapeutics, Inc. ( CDTX) - Key Metrics
Stock symbol CDTX is outdated, potentially delisted? Maybe it is available on other exchange?
CDTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | ? | -$3.40 | -$8.04 | -$8.06 |
| 2024Q2 | $0.07 | -$19.59 | -$22.74 | -$22.74 |
| 2024Q1 | $1.87 | -$2.28 | -$1.46 | -$1.47 |
| 2023Q4 | $3.91 | -$1.25 | -$2.83 | -$2.87 |
| 2023Q3 | $2.82 | -$1.81 | -$0.36 | -$0.39 |
CDTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -0.79 |
| 2024Q2 | ? | -0.15 |
| 2024Q1 | ? | -2.13 |
| 2023Q4 | ? | -3.18 |
| 2023Q3 | ? | -2.60 |
CDTX
Price: $221.38
52 week price:
Earnings Per Share: -11.21 USD
P/E Ratio: -19.72
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.0 million
Ebitda: -12.1 millionMarket Capitalization: 5.6 billion